Skip to main content

Kenneth A. Myszkowski

Equibles does not estimate personal net worth.

About Kenneth A. Myszkowski

Kenneth A. Myszkowski was last confirmed as CFO at Arrowhead Pharmaceuticals, Inc. (ARWR) in a filing dated January 29, 2025. The proxy statement of Arrowhead Pharmaceuticals, Inc. reports total compensation of $3,512,376 for Kenneth A. Myszkowski in fiscal 2024, including a base salary of $592,369. Disclosed compensation is on record for 5 fiscal years.

Affiliation history

Company network

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Arrowhead Pharmaceuticals, Inc. (ARWR) $592,369 $3,512,376
2023 Arrowhead Pharmaceuticals, Inc. (ARWR) $568,128 $3,119,143
2022 Arrowhead Pharmaceuticals, Inc. (ARWR) $509,648 $4,739,552
2021 Arrowhead Pharmaceuticals, Inc. (ARWR) $484,865 $5,333,570
2020 Arrowhead Pharmaceuticals, Inc. (ARWR) $463,750 $6,081,852

Recent activity

No call appearances or filed executive changes recorded yet.